Quantcast
Channel: Apple Tree Partners Archives - FinSMEs
Browsing all 33 articles
Browse latest View live

USA, Gloucester Pharmaceuticals closed a $29m series D financing

Gloucester Pharmaceuticals raised $29m in a Series D financing led by new investor Novo Ventures and included current investors Apple Tree Partners, ProQuest Investments, Prospect Venture Partners and...

View Article



Tokai Pharmaceuticals Raises $23M in Series D3 Financing

Tokai Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on developing new treatments for prostate cancer, has raised $23m in a Series D3 financing. Backers include...

View Article

Aileron Therapeutics Raises $12M in Series D Financing

Aileron Therapeutics, Inc., a Cambridge, Massachusetts-based biopharmaceutical company developing and advancing an innovative class of drugs called Stapled Peptides, raised $12m as a second tranche of...

View Article

Tokai Pharmaceuticals Raises $35.5M in Series E Financing

Tokai Pharmaceuticals, Inc., a Cambridge, Massachusetts-based biopharmaceutical company focused on developing new treatments for prostate cancer, raised $35.5m in a Series E financing. Backers included...

View Article

Aileron Therapeutics Secures $30M in Series E Equity Financing

Aileron Therapeutics, a Cambridge, MA-based clinical stage biopharmaceutical company, secured $30m in Series E equity financing. Backers included Apple Tree Partners, Roche Venture Fund, Novartis...

View Article


Tendyne Secures $25M in Series C Financing

Tendyne Holdings, Inc., a Roseville, MN-based clinical stage medical device company developing technologies for transcatheter mitral valve replacement, secured $25m in Series C financing. The round was...

View Article

Cerecor Closes First Tranche of $32M Series B Financing

Cerecor Inc., a Baltimore, MD-based clinical stage biopharmaceutical company developing treatments for patients suffering from nervous system disorders, closed the first tranche of a $32m Series B...

View Article

Aileron Therapeutics Secures Additional $33M in Series E Financing

Aileron Therapeutics, Inc., a Cambridge, MA-based clinical stage biopharmaceutical company that is developing therapeutics based on its proprietary Stapled Peptide drug platform, secured $33m in an...

View Article


VytronUS Secures $31.6M in Series B Financing

VytronUS, Inc., a Sunnyvale, CA-based medical device company developing novel technologies for the treatment of cardiac arrhythmias, secured $31.6m in Series B financing. The round was led by Apple...

View Article


Cure Forward Secures $15M in Series A Financing

Cure Forward, a New York City-based patient activation Company, secured $15m in Series A financing. The investment was made by Apple Tree Partners. The company intends to use the funds to create a...

View Article

Corvidia Therapeutics Raises $26M in Series A Funding

Corvidia Therapeutics, a Boston, MA-based biotechnology company focused on the development of precision cardiovascular therapies, raised $26m in Series A funding. The round was co-led by Sofinnova...

View Article

Syntimmune Raises Second $10M Tranche of $26M Series A Financing

Syntimmune, Inc., a New York-based development-stage company advancing novel treatments for IgG-mediated autoimmune diseases based on expertise in FcRn biology, raised a second $10m tranche of its $26m...

View Article

VytronUS Raises $49M in Series C Financing

VytronUS, Inc., a Sunnyvale, Calif.-based medical device company developing novel technologies for the treatment of cardiac arrhythmias, secured $49m in Series C equity financing. Backers included...

View Article


ROX Medical Raises $40M in Funding

ROX Medical, a San Clemente, CA-based clinical-stage medical device company developing technologies for hypertension, secured $40M in Series E financing. The round was led by Novartis Venture Fund and...

View Article

Syntimmune Raises $8M Tranche of $26M Series A Funding

Syntimmune, Inc., a Newton, MA- and New York, NY-based clinical-stage biotechnology company, raised the latest $8m tranche of its $26m Series A financing. Investors include Apple Tree Partners, Baxalta...

View Article


Syntimmune Closes $50M in Series B Financing

Syntimmune, Inc., a NYC-based clinical-stage biotechnology company focused on FcRn biology, raised $50m in Series B financing. The round was led by Apple Tree Partners, which has committed $48 million...

View Article

Elstar Therapeutics Closes $39M Series A Financing

Elstar Therapeutics, a Cambridge, Mass.-based precision cancer immunotherapy company, closed a $39M Series A financing. Founding backer Apple Tree Partners made the investment. The funds will be used...

View Article


Stoke Therapeutics Raises $40M in Series A Financing

Stoke Therapeutics, Inc., a Bedford, MA-based new company working to increase gene expression to treat a wide array of diseases caused by genetic insufficiency, completed a $40m Series A financing. The...

View Article

Braeburn Pharmaceuticals Completes $110M Mezzanine Round of Financing

Braeburn Pharmaceuticals, Inc., a Princeton, N.J.-based pharmaceutical company, completed a $110m mezzanine round of financing. The round was led by Wellington Capital Management with participation...

View Article

Corvidia Therapeutics Secures $60M in Series B Funding

Corvidia Therapeutics Inc., a Waltham, Mass.-based clinical stage biotechnology company, closed a $60m Series B funding round. The round was led by Venrock with participation from Andera (formerly...

View Article
Browsing all 33 articles
Browse latest View live




Latest Images